Spring Behrouz, Ph.D. (CEO) is a translational neuroscientist dedicated to the development of therapeutics that address unmet market needs.
— Sachs Associates (@SachsAssociates) February 22, 2021
e-Meet Spring at #Sachs_NIF
More info @ https://t.co/6YA6CPN7hE@VincereBio pic.twitter.com/36L7q9PIKG